Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity?

被引:9
作者
Block, TM
Mehta, AS
Blumberg, BS
Dwek, RA
机构
[1] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Drexel Inst Biotechnol & Virol Res, Doylestown, PA 18901 USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[3] Univ Oxford, Glycobiol Inst, Oxford OX1 2JD, England
关键词
D O I
10.1089/dna.2006.25.165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review discusses the nature of hepatitis B and C chronicity from a virological perspective. Work described in the literature and our in vitro studies of HBV polypeptide morphogenesis lead us to speculate about a role for HBsAg complex formation in immune evasion that may be especially important during the initial period of infection. Briefly, although viral structural proteins do eventually provide epitopes recognized by the host, we suggest that these HBs Ag complexes, which may themselves be refractory to proteasomal degradation, are an important way by which the virus shields its epitopes and evades early recognition by the cellular immune system. This suggests a central strategy by which the virus has evolved, structurally, to enable the establishment of persistent infection of its host. The concept offers an explanation for the nearly unidirectional and rapid kinetics whereby HBV proteins form multimers and generate a surplus of viral structures that have not been thought to serve any useful structural purpose.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 38 条
[1]   Molecular viral oncology of hepatocellular carcinoma [J].
Block, TM ;
Mehta, AS ;
Fimmel, CJ ;
Jordan, R .
ONCOGENE, 2003, 22 (33) :5093-5107
[2]   Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs [J].
Block, TM ;
Jordan, R .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2001, 12 (06) :317-325
[3]   Viruses, immunity, and cancer: Lessons from hepatitis B [J].
Chisari, FV .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1117-1132
[4]   Characterization of aggregates of hepatitis C virus glycoproteins [J].
Choukhi, A ;
Pillez, A ;
Drobecq, H ;
Sergheraert, C ;
Wychowski, C ;
Dubuisson, J .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :3099-3107
[5]   Cutting and pasting antigenic peptides [J].
Cresswell, P .
SCIENCE, 2004, 304 (5670) :525-527
[6]   Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin [J].
Dubuisson, J ;
Rice, CM .
JOURNAL OF VIROLOGY, 1996, 70 (02) :778-786
[7]  
FERRARI C, 1990, J IMMUNOL, V145, P3442
[8]   Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences [J].
Ganem, D ;
Prince, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1118-1129
[9]   Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations [J].
Geissler, M ;
Bruss, V ;
Michalak, S ;
Hockenjos, B ;
Ortmann, D ;
Offensperger, WB ;
Wands, JR ;
Blum, HE .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4284-4292
[10]   Generation of MHC class I peptide antigens by protein processing in the secretory route by furin [J].
Gil-Torregrosa, BC ;
Castaño, AR ;
López, D ;
Del Val, M .
TRAFFIC, 2000, 1 (08) :641-651